Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warner Chilcott Buyout Values Women’s Health Rx Firm At $3 Bil.

This article was originally published in The Pink Sheet Daily

Executive Summary

Buyout by DLJ and J.P. Morgan investment groups will complete transformation of U.K. company into U.S.-focused specialty women’s health firm. Investor group plans to retain current Warner Chilcott management following sale.

You may also be interested in...



Warner Chilcott Takes Itself Off The Market; Special Dividend Disappoints

Warner Chilcott has ended all discussions with parties potentially interested in buying the company and tried to satisfy investors with a special dividend as a consolation prize.

FTC, States Sue Barr, Warner Chilcott Over Ovcon-35 Deal

Lawsuit claims companies' agreement regarding generic Ovcon-35 was anti-competitive.

FTC, States Sue Barr, Warner Chilcott Over Ovcon-35 Deal

Lawsuit claims companies' agreement regarding generic Ovcon-35 was anti-competitive.

Topics

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel